Aurinia Pharmaceuticals Inc (AUPH) — Long-term Investment Intensity
Aurinia Pharmaceuticals Inc (AUPH) has a Long-term Investment Intensity of 0.0% as of June 2024. Long-term investments of $199.00K represent 0.0% of total assets of $523.53 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Aurinia Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aurinia Pharmaceuticals Inc Long-term Investment Intensity (2020–2023)
This chart shows how Aurinia Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2020 to 2023. As of June 2024, the intensity stands at 0.0%, reflecting long-term investments of $199.00K against total assets of $523.53 Million USD. Also explore total assets of Aurinia Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Aurinia Pharmaceuticals Inc (2020–2023)
The table below presents the year-by-year Long-term Investment Intensity for Aurinia Pharmaceuticals Inc from 2020 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Aurinia Pharmaceuticals Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.0% | $201.00K | $548.06 Million | ▼ -5.2 pp |
| 2020 | 5.3% | $24.38 Million | $463.66 Million | — |